Molecule reduces tau protein, may reverse damage.

In Alzheimer's, Brain Science, Genetics by Brainy Days Ahead

Researchers at Washington University School of Medicine in St. Louis have shown that levels of the tau protein can be reduced, along with some of the neurological damage, by a synthetic molecule that targets the genetic instructions for building the tau protein. The molecule, known as an antisense oligonucleotide, potentially could treat neurodegenerative diseases characterized by abnormal tau, including Alzheimer’s.